Figure 7.
(A), Plasma glucose, (B) insulin, and (C) free fatty acids levels in the fasting rats after treatment with CFB, DCA12, 4-MP, and TDYA. D, liver citrate and (E) malonyl-CoA content were not significantly altered in the fasting rats after treatment with CFB, DCA12, 4-MP, and TDYA. F, liver acetyl-CoA content was reduced in the fasting rats after treatment with CFB or DCA12. (G) Liver free CoA, (H) malate, (I) alanine, (J) aspartate, and (K) glutamate levels in the fasting rats were not significantly altered after treatment with CFB, DCA12, 4-MP, or TDYA. Mean ± SEM, n = 8, ∗p < 0.05 by t-test between paired conditions.